Think of stem cells as the body's own biological building blocks. Researchers are studying how, when something goes wrong — an injury, a chronic condition, or ongoing inflammation — the body sends out signals for help, and whether stem cells may respond to those signals in meaningful ways.

Ongoing clinical research explores whether stem cells introduced into the body travel toward areas of concern, release natural compounds, and may help the immune system when it is overreacting. These are areas of active scientific investigation, not established clinical conclusions.

Three areas scientists continue investigating:

• 🔹 Paracrine signaling — Researchers are studying whether stem cells release natural compounds that may communicate with surrounding tissue.
• 🔹 Targeted migration — Current evidence suggests stem cells may have a tendency to migrate toward areas of injury or inflammation.
• 🔹 Immune modulation — In conditions where the immune system is dysregulated, scientists continue investigating whether stem cells may play a role in restoring balance.

There is no universal protocol. The method of delivery evaluated by physicians depends on the patient's health profile, medical history, and the specific clinical context under investigation.

Methods currently being used in clinical research settings:

• 🩸 Intravenous infusion (IV) — Stem cells administered via IV drip travel through the bloodstream. Researchers are studying how systemic delivery may allow cells to reach various tissues.
• 💉 Direct injection — For localized areas such as joints or targeted tissue regions, researchers are exploring direct injection as a delivery mechanism.
• 🧠 Intrathecal administration — For certain neurological research applications, cells may be introduced into the cerebrospinal fluid by a specialist in a controlled setting.

Stem cell research is one of the most active fields in modern medicine. Thousands of clinical trials are currently underway globally — from major academic medical centers to specialized regenerative medicine facilities.

What current evidence suggests:

• ✅ Some cell-based applications — such as bone marrow transplantation for certain blood disorders — have been used in clinical settings for decades.
• ✅ Ongoing clinical research explores potential roles in various neurological, autoimmune, and metabolic conditions.
• ✅ Researchers continue investigating safety profiles, optimal delivery methods, and patient selection criteria.

What is important to understand:

• ⚠️ Regenerative medicine continues to evolve. No specific outcomes are guaranteed.
• ⚠️ Individual responses vary based on age, health status, and other factors.
• ⚠️ The level of research evidence differs across different areas of investigation.

This is one of the most important questions patients explore, and it deserves a thorough answer.

Research conducted in qualified, certified medical facilities with proper laboratory controls shows a generally favorable safety profile in current studies. Risks associated with unregulated settings, unverified cell sources, or absent patient screening are substantially higher.

What to look for when evaluating any regenerative medicine program:

• ✅ Regulatory certification — In Mexico, COFEPRIS is the regulatory body governing biotechnology treatments. GIOSTAR Mexico operates under this framework.
• ✅ In-house, certified laboratory — Cells should be processed in a controlled, sterile environment with full quality oversight.
• ✅ Comprehensive medical evaluation — A responsible program reviews each patient's complete health history before any evaluation proceeds.

• ✅ Licensed, experienced medical team — Physicians with specific training in regenerative medicine should oversee each case.
• ✅ Transparent follow-up — A responsible program tracks patients and provides structured post-visit monitoring.